Drug Profile
KB 126
Latest Information Update: 21 Dec 2016
Price :
$50
*
At a glance
- Originator Unknown
- Developer Karo Bio
- Class Antiarrhythmics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Arrhythmias
Most Recent Events
- 03 Sep 1998 No-Development-Reported for Arrhythmias in Sweden (Unknown route)
- 15 Apr 1996 Preclinical development for Arrhythmias in Sweden (Unknown route)